The Life Sciences industry is constantly evolving and looking for ways to maintain robust regulatory compliance and keep staff and sites safe.
Recipharm AB is one of the five largest pharmaceutical contract development and manufacturing organisations in the world. They are further safeguarding their operations by signing a contract for new IBM Maximo licences, provided by Peacock Engineering.
This new system will help them to:
- Ensure robust regulatory compliance
- Reduce risk (and compliance costs)
- Maximize asset utilization & performance
- Boost product quality
- Reduce overall IT complexity
Compliance risk is reduced through the reduction of human errors, including decreasing paperwork, duplication of work and the increased availability of retrievable audit trails.
Peacock Engineering looks forward to helping Recipharm AB do all of the above.